The prevalence of cancer in patients with Multiple Sclerosis (MS) who were under treatment with Natalizumab (Tysabri): A systematic review and meta-analysis

Background: To determine the pooled prevalence of cancer in subjects with multiple sclerosis (MS) who received Natalizumab. Methods: Two researchers systematically searched PubMed, Scopus, EMBASE, Web of Science, google scholar, and gray literature including references of the included studies. The s...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Amirreza Nasirzadeh, Reza Jahanshahi, Mahsa Ghajarzadeh, Aida Mohammadi, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wolters Kluwer Medknow Publications 2023-01-01
Rangatū:	International Journal of Preventive Medicine
Ngā marau:	multiple sclerosis neoplasm prevalence
Urunga tuihono:	http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2023;volume=14;issue=1;spage=114;epage=114;aulast=Nasirzadeh
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!